Effects of lifestyle and genetic polymorphisms on consumption of coffee or black tea and urinary caffeine levels

Biomarkers

Volumn 3, Issue 4-5, 1998, Pages 367-377

  Yang, Mihi ^a   Kawamoto, Toshihiro ^a   Katoh, Takahiko ^a   Mastuno, Koji ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Black tea; Caffeine; Coffee; Genetic polymorphisms; Smoking

Indexed keywords

CAFFEINE;

ADULT; AGED; ARTICLE; COFFEE; DIETARY INTAKE; DNA POLYMORPHISM; GENOTYPE; HABIT; HUMAN; LIFESTYLE; MALE; NORMAL HUMAN; SMOKING; TEA; URINALYSIS; URINARY EXCRETION;

EID: 0031660969     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475098231165     Document Type: Article

References (24)

1. ABE, M., SUZUKI, T. and DEGUCHI, T. 1993, An improved method for genotyping of N-acetyltransferases polymorphism by polymerase chain reaction. Japanese Journal of Human Genetics (TOKYO), 38, 163-168.
2. BERTHOU, F., FLINOIS, J., RATANASAVANH, D., BEAUNE, P., RICHE, C. and GUILLOUZO, A, 1991, Evidence for the involvement of several cytochromes P450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metabolism and Disposition, 19, 561-567.
3. BIRKETT, D. J, and MINERS, J. O. 1991, Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events. British Journal of Clinical Pharmacology, 31, 405-408.
4. BROWN, C, R., JACOBIII, P., WILSON, M, and BENOWITZ, N. L. 1988, Changes in rate and pattern of caffeine metabolism after cigarette abstinence. Clinical Pharmacology and Therapeutics, 43, 488-491.
5. CARRILLO, J. A. and BENITEZ, J. 1994, Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways. Clinical Pharmacology and Therapeutics, 55, 293-304.
6. DEGUCHI, T. 1992, Molecular pharmacology of polymorphic arylamine N-acetyltransferase involved in the metabolism of arylamine drugs. Nihonn Rinshou, 50, 209-218.
7. GONZALEZ, F. J. and GELBOIN, H. V. 1992, Human cytochrome P450: evolution and cDNA-directed expression. Environmental Health Perspectives, 98, 81-85.
8. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, WHO 1991, IARC monographs on the evaluation of carcinogenic risks to humans; coffee, tea, mate, methylxanthines and methyl glyoxal (Lyon, France: IARC).
9. KALOW, W. 1985, Variability of caffeine metabolism in human. Arzeimittel-Forschung/Drug Research, 35, 319-324.
10. KAWAJIRI, K., NAKACHI, K., IMAI, K., WATANABE, J. and HAYASHI, S. 1993, The CYP1A1 gene and cancer susceptibility. Critical Reviews in Oncology/Hematology, 14, 77-87.
11. KAWAMOTO, T., YOSHIKAWA, M., MATSUNO, K., KAYAMA, F., OYAMA, T., ARASHIDANI, K. and KODAMA, Y. 1993, Effects of side-stream cigarette smoke on the hepatic cytochrome p450. Archives of Environmental and Contamination Toxicology, 25, 255-25.
12. KAWAMOTO, T., KOGA, M., MURATA, K., MATSUDA, S. and KODAMA, Y. 1995, Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans. Toxicology and Applied Pharmacology, 133, 295-304.
13. OGATA, M. and TAGUCHI, T. 1986, Quantitative analysis of urinary glycine conjugates by high performance liquid chromatography: excretion of hippuric acid and methyl hippuric acids in the urine of subjects exposed to vapors of toluene and xylene. International Archives of Occupational and Environmental Health, 58, 121-129.
14. OYAMA, T., MITSUDOMI, T., KAWAMOTO, T., OGAMI, A., OSAKI. T., KODAMA, Y. and YASUMOTO, K. 1995, Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes (in Japanese). International Archives of Occupational and Environmental Health, 67, 253-256.
15. PERSSON, I., JOHANSSON, I. and INGELMAN-SUNDBERG, M. 1997, In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochemical and Biophysical Research Communications, 231, 227-230.
16. RESOURCES COUNCIL, SCIENCE and TECHNOLOGY AGENCY, JAPAN 1995, Standard tables of food composition in Japan. 4th edition (in Japanese) (Tokyo: The Ministry of Finance Pub.), pp. 272-277.
17. SHIBUTA, K., NAKASHIMA, T., ABE, M., MASHIMO, M., MORI, M., UEO, H., AKIYUOSHI, T., SUGIMACHI, K. and SUZUKI, T. 1994, Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer, 74, 3108-3112.
18. TAKEDA, N., JITSNARI, F., ASAKAWA, F., SUNA, S., MANABE, Y., FUKUNAGA, I. and GOTOH, A. 1993, Simultaneous determination of cotinine and creatinine by high performance liquid chromatography. Japanese Industrial Health , 35, 198-199.
19. TASSANEEYAKUL, W., MOHAMED, Z., BIRKETT, D. J., MCMANUS, M. E., VERONESE M. E., TUKEY, R. H., QUATTROCHI, L. C., GONZALES, F. J. and MINERS, J. O. 1992, Caffeine as probe for human cytochrome P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. Pharmacogenetics, 2, 173-183.
20. TASSANEEYAKUL, W., BIRKETT, D. J., MCMANUS , M. E., TASSANNEEYAKUL, W., VERONESE M. E., AndERSSON, T., TUKEY, R. H. and MINERS, J. O. 1994, Caffeine as metabolism by human hepatic cytochromes P450: contributions of CYP1A2, 2E1 and 3A isoforms. Biochemical Pharmacology, 47, 1767-1776.
21. TSUKADA, M., MOGI, T. and KOIZUMI, A. 1996, Relationship between preference of coffee and NAT phenotypes which are determined by PCR (in Japanese). Japanese Journal of Hygiene, 51, 394.
22. VINEIS, P. 1993, Hypothesis: coffee consumption, N-acetyltransferase phenotype, and cancer. Journal of National Cancer Institute, 85, 1004-1005.
23. VISTISEN, K., POLSEN, H. E. and LOFT, S. 1992, Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis, 13, 1561-1568.
24. WATANABE, J., HAYASHI, S. and KAWAJIRI, K. 1994, Different regulation and expression of the human CYP2E1gene due to the RsaI polymorphism in the 5'-flanking region. Journal of Biochemistry, 116, 321-326.